BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

558 related articles for article (PubMed ID: 25654623)

  • 21. Complement Involvement in Periodontitis: Molecular Mechanisms and Rational Therapeutic Approaches.
    Hajishengallis G; Maekawa T; Abe T; Hajishengallis E; Lambris JD
    Adv Exp Med Biol; 2015; 865():57-74. PubMed ID: 26306443
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pathogenic strategies of the oral anaerobe, Porphyromonas gingivalis.
    Cutler CW; Kalmar JR; Genco CA
    Trends Microbiol; 1995 Feb; 3(2):45-51. PubMed ID: 7728384
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proteases of Porphyromonas gingivalis: what don't they do?
    Kuramitsu HK
    Oral Microbiol Immunol; 1998 Oct; 13(5):263-70. PubMed ID: 9807117
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Porphyromonas gingivalis-epithelial cell interactions in periodontitis.
    Andrian E; Grenier D; Rouabhia M
    J Dent Res; 2006 May; 85(5):392-403. PubMed ID: 16632751
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolic crosstalk regulates Porphyromonas gingivalis colonization and virulence during oral polymicrobial infection.
    Kuboniwa M; Houser JR; Hendrickson EL; Wang Q; Alghamdi SA; Sakanaka A; Miller DP; Hutcherson JA; Wang T; Beck DAC; Whiteley M; Amano A; Wang H; Marcotte EM; Hackett M; Lamont RJ
    Nat Microbiol; 2017 Nov; 2(11):1493-1499. PubMed ID: 28924191
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Uniquely Altered Oral Microbiome Composition Was Observed in Pregnant Rats With
    Walkenhorst MS; Reyes L; Perez G; Progulske-Fox A; Brown MB; Phillips PL
    Front Cell Infect Microbiol; 2020; 10():92. PubMed ID: 32211345
    [No Abstract]   [Full Text] [Related]  

  • 27. Complement and dysbiosis in periodontal disease.
    Hajishengallis G; Lambris JD
    Immunobiology; 2012 Nov; 217(11):1111-6. PubMed ID: 22964237
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Critical assessment of microbiological diagnostics in periodontal diseases with special focus on Porphyromonas gingivalis].
    Walter C; Purucker P; Bernimoulin JP; Suttorp N; Meyer J; Weiger R
    Schweiz Monatsschr Zahnmed; 2005; 115(5):415-24. PubMed ID: 15960451
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Porphyromonas gingivalis neutrophil manipulation: risk factor for periodontitis?
    Darveau RP
    Trends Microbiol; 2014 Aug; 22(8):428-9. PubMed ID: 25001854
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Liver X receptors contribute to periodontal pathogen-elicited inflammation and oral bone loss.
    Huang N; Shaik-Dasthagirisaheb YB; LaValley MP; Gibson FC
    Mol Oral Microbiol; 2015 Dec; 30(6):438-50. PubMed ID: 25946408
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Porphyromonas gingivalis antigenic determinants--potential targets for the vaccine development against periodontitis.
    Grover V; Kapoor A; Malhotra R; Kaur G
    Infect Disord Drug Targets; 2014; 14(1):1-13. PubMed ID: 25159307
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Can Better Management of Periodontal Disease Delay the Onset and Progression of Alzheimer's Disease?
    Harding A; Robinson S; Crean S; Singhrao SK
    J Alzheimers Dis; 2017; 58(2):337-348. PubMed ID: 28453484
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of
    Frey AM; Satur MJ; Phansopa C; Honma K; Urbanowicz PA; Spencer DIR; Pratten J; Bradshaw D; Sharma A; Stafford G
    Microbiology (Reading); 2019 Nov; 165(11):1181-1197. PubMed ID: 31517596
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The oral microbiome and the immunobiology of periodontal disease and caries.
    Costalonga M; Herzberg MC
    Immunol Lett; 2014 Dec; 162(2 Pt A):22-38. PubMed ID: 25447398
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Involvement of Porphyromonas gingivalis fimA genotype in treatment outcome following non-surgical periodontal therapy.
    Fujise O; Miura M; Hamachi T; Maeda K
    J Periodontol; 2005 Oct; 76(10):1661-6. PubMed ID: 16253087
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Contribution of -Omics Technologies in the Study of
    Nuñez-Belmar J; Morales-Olavarria M; Vicencio E; Vernal R; Cárdenas JP; Cortez C
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36614064
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Porphyromonas gingivalis-host interactions: open war or intelligent guerilla tactics?
    Hajishengallis G
    Microbes Infect; 2009; 11(6-7):637-45. PubMed ID: 19348960
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genotype variation and capsular serotypes of Porphyromonas gingivalis from chronic periodontitis and periodontal abscesses.
    Yoshino T; Laine ML; van Winkelhoff AJ; Dahlén G
    FEMS Microbiol Lett; 2007 May; 270(1):75-81. PubMed ID: 17439635
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Porphyromonas gingivalis: the gift of community involvement.
    Fletcher HM
    Mol Oral Microbiol; 2018 Apr; 33(2):111-112. PubMed ID: 29461020
    [No Abstract]   [Full Text] [Related]  

  • 40. Biogenesis and function of Porphyromonas gingivalis outer membrane vesicles.
    Xie H
    Future Microbiol; 2015; 10(9):1517-27. PubMed ID: 26343879
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.